These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7590140)

  • 1. The effect of omeprazole on human natural killer cell activity.
    Aybay C; Imir T; Okur H
    Gen Pharmacol; 1995 Oct; 26(6):1413-8. PubMed ID: 7590140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity inhibition of cytolytic lymphocytes by omeprazole.
    Scaringi L; Cornacchione P; Fettucciari K; Rosati E; Rossi R; Marconi P; Capodicasa E
    Scand J Immunol; 1996 Sep; 44(3):204-14. PubMed ID: 8795713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lansoprazole on human leukocyte function.
    Capodicasa E; De Bellis F; Pelli MA
    Immunopharmacol Immunotoxicol; 1999 May; 21(2):357-77. PubMed ID: 10319286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omeprazole inhibits natural killer cell functions.
    Alkim H; Unal S; Okur H; Imir T
    Dig Dis Sci; 2008 Feb; 53(2):347-51. PubMed ID: 17597410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.
    Mattsson JP; Väänänen K; Wallmark B; Lorentzon P
    Biochim Biophys Acta; 1991 Jun; 1065(2):261-8. PubMed ID: 1647821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effects of H+ K+ ATPase inhibitors on human neutrophils in vitro: restoration by a K+ ionophore.
    Martins de Oliveira R; Antunes E; Pedrazzoli J; Gambero A
    Inflamm Res; 2007 Mar; 56(3):105-11. PubMed ID: 17406807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245.
    Wandall JH
    Gut; 1992 May; 33(5):617-21. PubMed ID: 1319381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori augments the acid inhibitory effect of omeprazole on parietal cells and gastric H(+)/K(+)-ATPase.
    Beil W; Sewing KF; Busche R; Wagner S
    Gut; 2001 Feb; 48(2):157-62. PubMed ID: 11156634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole inhibits phagocytosis and acidification of phagolysosomes of normal human neutrophils in vitro.
    Agastya G; West BC; Callahan JM
    Immunopharmacol Immunotoxicol; 2000 May; 22(2):357-72. PubMed ID: 10952036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omeprazole: mode of action and effect on acid secretion in animals.
    Wallmark B
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():101-6. PubMed ID: 2657278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organophosphorus pesticides markedly inhibit the activities of natural killer, cytotoxic T lymphocyte and lymphokine-activated killer: a proposed inhibiting mechanism via granzyme inhibition.
    Li Q; Nagahara N; Takahashi H; Takeda K; Okumura K; Minami M
    Toxicology; 2002 Apr; 172(3):181-90. PubMed ID: 11893417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted thieno[3,4-d]imidazoles, a novel group of H+/K(+)-ATPase inhibitors. Differentiation of their inhibition characteristics from those of omeprazole.
    Beil W; Staar U; Sewing KF
    Eur J Pharmacol; 1990 Oct; 187(3):455-67. PubMed ID: 1963594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omeprazole, SCH 28080 and doxepin differ in their characteristics to inhibit H+/K+-ATPase driven proton accumulation by parietal cell membrane vesicles.
    Beil W; Staar U; Schünemann P; Sewing KF
    Biochem Pharmacol; 1988 Dec; 37(23):4487-93. PubMed ID: 2849447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reduced ex vivo production of superoxide anion by polymorphonuclear leukocytes during therapy with omeprazole. A pharmacological effect?].
    Capodicasa E; Ciaccio V; Corazzi F; De Bellis F; Bucaneve G; Ficola F; Pelli MA
    Minerva Gastroenterol Dietol; 1994 Sep; 40(3):105-11. PubMed ID: 7948319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effects of meropenem and imipenem/cilastatin on some functions of human natural effector cells.
    Cornacchione P; Scaringi L; Capodicasa E; Fettucciari K; Rosati E; Sabatini R; Benedetti C; Marconi P; Rossi R; Del Favero A
    Chemotherapy; 2000; 46(2):135-42. PubMed ID: 10671765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of omeprazole on eicosanoid formation in and release from guinea-pig gastric mucosal cells.
    Hell M; Sewing KF
    Br J Pharmacol; 1987 May; 91(1):69-75. PubMed ID: 3297228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pantoprazole: a novel H+/K(+)-ATPase inhibitor with an improved pH stability.
    Beil W; Staar U; Sewing KF
    Eur J Pharmacol; 1992 Aug; 218(2-3):265-71. PubMed ID: 1330598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of in vitro exposure to low levels of organotin and carbamate pesticides on human natural killer cell cytotoxic function.
    Wilson S; Dzon L; Reed A; Pruitt M; Whalen MM
    Environ Toxicol; 2004 Dec; 19(6):554-63. PubMed ID: 15526271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.